334 related articles for article (PubMed ID: 12592634)
21. Embryonal hyperplasia of Bowman's capsular epithelium in patients with WT1 mutations.
Fukuzawa R; Eccles MR; Ikeda M; Hata J
Pediatr Nephrol; 2003 Jan; 18(1):9-13. PubMed ID: 12488983
[TBL] [Abstract][Full Text] [Related]
22. Bilateral gonadoblastoma with dysgerminoma and pilocytic astrocytoma with WT1 GT-IVS9 mutation: A 46 XY phenotypic female with Frasier syndrome.
Subbiah V; Huff V; Wolff JE; Ketonen L; Lang FF; Stewart J; Langford L; Herzog CE
Pediatr Blood Cancer; 2009 Dec; 53(7):1349-51. PubMed ID: 19653292
[TBL] [Abstract][Full Text] [Related]
23. Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study.
Little SE; Hanks SP; King-Underwood L; Jones C; Rapley EA; Rahman N; Pritchard-Jones K
J Clin Oncol; 2004 Oct; 22(20):4140-6. PubMed ID: 15483024
[TBL] [Abstract][Full Text] [Related]
24. [Frasier syndrome: a rare syndrome with WT1 gene mutation in pediatric urology].
Zugor V; Zenker M; Schrott KM; Schott GE
Aktuelle Urol; 2006 Jan; 37(1):64-6. PubMed ID: 16440249
[TBL] [Abstract][Full Text] [Related]
25. Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations.
Schumacher V; Schärer K; Wühl E; Altrogge H; Bonzel KE; Guschmann M; Neuhaus TJ; Pollastro RM; Kuwertz-Bröking E; Bulla M; Tondera AM; Mundel P; Helmchen U; Waldherr R; Weirich A; Royer-Pokora B
Kidney Int; 1998 Jun; 53(6):1594-600. PubMed ID: 9607189
[TBL] [Abstract][Full Text] [Related]
26. Germline WT1 mutations in Wilms' tumor patients: preliminary results.
Li FP; Breslow NE; Morgan JM; Ghahremani M; Miller GA; Grundy PE; Green DM; Diller LR; Pelletier J
Med Pediatr Oncol; 1996 Nov; 27(5):404-7. PubMed ID: 8827066
[TBL] [Abstract][Full Text] [Related]
27. WT1 intron 9 splice acceptor site mutation in a 46,XY male with focal segmental glomerulosclerosis.
Kanemoto K; Ishikura K; Ariyasu D; Hamasaki Y; Hataya H; Hasegawa Y; Ikeda M
Pediatr Nephrol; 2007 Mar; 22(3):454-8. PubMed ID: 17061122
[TBL] [Abstract][Full Text] [Related]
28. Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database.
Jeanpierre C; Denamur E; Henry I; Cabanis MO; Luce S; Cécille A; Elion J; Peuchmaur M; Loirat C; Niaudet P; Gubler MC; Junien C
Am J Hum Genet; 1998 Apr; 62(4):824-33. PubMed ID: 9529364
[TBL] [Abstract][Full Text] [Related]
29. Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population.
Orloff MS; Iyengar SK; Winkler CA; Goddard KA; Dart RA; Ahuja TS; Mokrzycki M; Briggs WA; Korbet SM; Kimmel PL; Simon EE; Trachtman H; Vlahov D; Michel DM; Berns JS; Smith MC; Schelling JR; Sedor JR; Kopp JB
Physiol Genomics; 2005 Apr; 21(2):212-21. PubMed ID: 15687485
[TBL] [Abstract][Full Text] [Related]
30. Exon 9 mutations in the WT1 gene, without influencing KTS splice isoforms, are also responsible for Frasier syndrome.
Kohsaka T; Tagawa M; Takekoshi Y; Yanagisawa H; Tadokoro K; Yamada M
Hum Mutat; 1999; 14(6):466-70. PubMed ID: 10571943
[TBL] [Abstract][Full Text] [Related]
31. Frasier syndrome comes full circle: genetic studies performed in an original patient.
Wang NJ; Song HR; Schanen NC; Litman NL; Frasier SD
J Pediatr; 2005 Jun; 146(6):843-4. PubMed ID: 15973330
[TBL] [Abstract][Full Text] [Related]
32. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis.
Patek CE; Fleming S; Miles CG; Bellamy CO; Ladomery M; Spraggon L; Mullins J; Hastie ND; Hooper ML
Hum Mol Genet; 2003 Sep; 12(18):2379-94. PubMed ID: 12915483
[TBL] [Abstract][Full Text] [Related]
33. Expanding the clinical spectrum of Frasier syndrome.
Gwin K; Cajaiba MM; Caminoa-Lizarralde A; Picazo ML; Nistal M; Reyes-Múgica M
Pediatr Dev Pathol; 2008; 11(2):122-7. PubMed ID: 17378674
[TBL] [Abstract][Full Text] [Related]
34. A novel WT1 gene mutation in a newborn infant diagnosed with Denys-Drash syndrome.
Hakan N; Aydin M; Erdogan O; Cavusoglu YH; Aycan Z; Ozaltin F; Zenciroglu A; Apaydin S; Gunes R; Sahin G; Cinar G; Okumus N
Genet Couns; 2012; 23(2):255-61. PubMed ID: 22876585
[TBL] [Abstract][Full Text] [Related]
35. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
[TBL] [Abstract][Full Text] [Related]
36. WT1 Pathogenic Variants are Associated with a Broad Spectrum of Differences in Sex Development Phenotypes and Heterogeneous Progression of Renal Disease.
Ferrari MTM; Watanabe A; da Silva TE; Gomes NL; Batista RL; Nishi MY; de Paula LCP; Costa EC; Costa EMF; Cukier P; Onuchic LF; Mendonca BB; Domenice S
Sex Dev; 2022; 16(1):46-54. PubMed ID: 34392242
[TBL] [Abstract][Full Text] [Related]
37. 46,XY phenotypic male with focal segmental glomerulosclerosis caused by the WT1 splice site mutation.
Tajima T; Sasaki S; Tanaka Y; Kusunoki H; Nagashima T; Nonomura K; Fujieda K
Horm Res; 2003; 60(6):302-5. PubMed ID: 14646409
[TBL] [Abstract][Full Text] [Related]
38. A female infant with Frasier syndrome showing splice site mutation in Wilms' tumor gene (WT1) intron 9.
Fujita S; Sugimoto K; Miyazawa T; Yanagida H; Tabata N; Okada M; Takemura T
Clin Nephrol; 2010 Jun; 73(6):487-91. PubMed ID: 20497763
[TBL] [Abstract][Full Text] [Related]
39. A novel WT1 heterozygous nonsense mutation (p.K248X) causing a mild and slightly progressive nephropathy in a 46,XY patient with Denys-Drash syndrome.
da Silva TE; Nishi MY; Costa EM; Martin RM; Carvalho FM; Mendonca BB; Domenice S
Pediatr Nephrol; 2011 Aug; 26(8):1311-5. PubMed ID: 21559934
[TBL] [Abstract][Full Text] [Related]
40. Mother-to-child transmitted WT1 splice-site mutation is responsible for distinct glomerular diseases.
Denamur E; Bocquet N; Mougenot B; Da Silva F; Martinat L; Loirat C; Elion J; Bensman A; Ronco PM
J Am Soc Nephrol; 1999 Oct; 10(10):2219-23. PubMed ID: 10505700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
